NL – Gongslag ter ere van 1 jaar beursnotering

November 1, 2010 Group News

Cryo-Save Group N.V. Gongslag ter ere van 1 jaar beursnotering

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), de grootste stamcelbank van Europa, heeft vandaag om 9 uur de handelsdag geopend met de gongslag ter ere van 1 jaar notering aan NYSE Euronext Amsterdam.
Het aandeel Cryo-Save heeft een significante groei laten zien van de liquiditeit gedurende dit eerste jaar.

read more

EN – Rings the opening bell to celebrate its first full year on euronext

November 1, 2010 Group News

Cryo-Save Group N.V. rings the opening bell to celebrate its first full year on Euronext

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading adult stem cell storage bank, has rung the opening bell at NYSE Euronext Amsterdam today to mark its first full year of being listed on the exchange.
Cryo-Save noticed a significant growth in liquidity of its shares during this year.

read more

EN – Appointment liquidity provider

August 6, 2010 Group News

Cryo-Save appoints Kempen & Co as liquidity provider

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading stem cell bank, today announces that it has decided to appoint Kempen & Co as liquidity provider as of 2 August 2010.

With the appointment of a liquidity provider Cryo-Save aims to enhance the liquidity of its shares on Euronext Amsterdam.

read more

NL – Benoeming liquidity provider

August 6, 2010 Group News

Cryo-Save benoemt Kempen & Co als liquidity provider

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), de grootste stamcelbank van Europa, maakt vandaag bekend Kempen & Co per 2 augustus 2010 te hebben benoemd als liquidity provider.

Met het aanstellen van een liquidity provider stelt Cryo-Save zich ten doel de liquiditeit van het aandeel op Euronext Amsterdam te vergroten.

read more

Admission to trading on Euronext

October 22, 2009 Group News

This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, South Africa or any jurisdiction in which the same would be unlawful. This announcement is not an offer of securities in the United States, Canada, South Africa, Australia, Japan or any other jurisdiction.

read more

Publication of the prospectus and listing on Euronext Amsterdam

October 13, 2009 Group News

This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, South Africa or any jurisdiction in which the same would be unlawful. This announcement is not an offer of securities in the United States, Canada, South Africa, Australia, Japan or any other jurisdiction.

read more

Cryo-Save convenes EGM

September 18, 2009 Group News

This announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, South Africa or any jurisdiction in which the same would be unlawful. This announcement is not an offer of securities in the United States, Canada, South Africa, Australia, Japan or any jurisdiction in which the same would be unlawful.

read more

Cryo-Save plans to list on Euronext

September 3, 2009 Group News

Cryo-Save Group N.V. (AIM: CRYO, “Cryo-Save”), Europe’s leading stem cell bank, plans to seek an additional listing on Euronext Amsterdam in the fourth quarter of the current financial year to complement the Group’s shares being traded on AIM in London. Cryo-Save was admitted to trading on AIM on 6 November 2007.

Cryo-Save intends to review the need to maintain the AIM listing in early 2010.

read more